NAUT
Nautilus Biotechnology Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.33
+0.04 ▲ +1.75%
🌙 3월 13일 6:47 PM ET (한국 3/14 07:47)
$2.41
+0.08 ▲ +3.43%
| Index | - | P/E | - | EPS (ttm) | -0.47 | Insider Own | 52.45% | Shs Outstand | 0.13B | Perf Week | -5.67% |
| Market Cap | 0.29B | Forward P/E | - | EPS next Y | - | Insider Trans | 0.04% | Shs Float | 0.06B | Perf Month | 7.87% |
| Enterprise Value | 0.22B | PEG | - | EPS next Q | -0.14 | Inst Own | 26.06% | Short Float | 0.65% | Perf Quarter | 14.22% |
| Income | -0.06B | P/S | - | EPS this Y | -17.02% | Inst Trans | 1.5% | Short Ratio | 1.82 | Perf Half Y | 229.93% |
| Sales | 0.00B | P/B | 1.88 | EPS next 5Y | 2.17% | ROA | -27.2% | Short Interest | 0.39M | Perf YTD | 19.49% |
| Book/sh | 1.24 | P/C | 2.85 | EPS past 3/5Y | -0.17% 0.21% | ROE | -32.27% | 52W High | -24.35% ($3.08) | Perf Year | 119.81% |
| Cash/sh | 0.82 | P/FCF | - | Sales past 3/5Y | - | ROIC | -32.21% | 52W Low | 275.81% ($0.62) | Perf 3Y | 14.78% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 17.19% | Gross Margin | - | Volatility(W/M) | 9.02% 11.67% | Perf 5Y | -84.03% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.24 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 13.33 | EPS Q/Q | 22.09% | Profit Margin | - | RSI (14) | 47.6 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 13.33 | Sales Q/Q | - | SMA20 | -8.23% ($2.54) | Beta | 1.35 | Target Price | $4 |
| Payout | - | Debt/Eq | 0.19 | Earnings | 2000000 | SMA50 | 3.8% ($2.24) | Rel Volume | 0.67 | Prev Close | $2.29 |
| Employees | 130 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | 21.43% - | SMA200 | 66.87% ($1.4) | Avg Volume(3M) | 0.22M | Price | $2.33 |
| IPO | 2020/8/7 | Option/Short | Yes/Yes | Trades | 943 | Volume | 144,082 | Change | 1.75% |
뉴스 로딩 중...